# Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy

> **NCT07423650** · PHASE4 · RECRUITING · sponsor: **Iuliu Hatieganu University of Medicine and Pharmacy** · enrollment: 93 (estimated)

## Conditions studied

- Pancreatoduodenectomy
- Pain Management
- Opioid Analgesia
- Multimodal Analgesia

## Interventions

- **DRUG:** Nefopam 120mg/day infusion
- **DRUG:** Lidocaine Infusion
- **DRUG:** Peridural
- **DRUG:** Multimodal IV analgesia

## Key facts

- **NCT ID:** NCT07423650
- **Lead sponsor:** Iuliu Hatieganu University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 93 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423650, "Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07423650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*